Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
| Autor: | Georgoulias, V. *, Bozionelou, V., Agelaki, S., Perraki, M., Apostolaki, S., Kallergi, G., Kalbakis, K., Xyrafas, A., Mavroudis, D. |
|---|---|
| Zdroj: | In Annals of Oncology July 2012 23(7):1744-1750 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|